EMD-49835

Single-particle
3.0 Å
EMD-49835
3D View Gallery
Deposition: 20/03/2025
Map released: 25/02/2026
Last modified: 29/04/2026
Overview 3D View Sample Experiment Validation Additional data Links
Overview 3D View Sample Experiment Validation Additional data Links

EMD-49835
Download
3D volume (map.gz) Experimental metadata (xml) Experimental Metadata (cif.gz)
Map-only Validation report (pdf.gz) Map-only Validation report (cif.gz) Map-only Validation report (xml.gz)
Map and PDB model 9nvg summary report (pdf.gz) Map and 9nvg FULL report (pdf.gz)
EMICSS annotations (xml)

SARS-CoV-2 BA.1 S6P (HexaPro) + COV2-3835 Fab Local Refinement Map (RBD + Fv)

EMD-49835

Single-particle
3.0 Å
EMD-49835
3D View Gallery
Deposition: 20/03/2025
Map released: 25/02/2026
Last modified: 29/04/2026
Overview 3D View Sample Experiment Validation Additional data Links
Sample Organism: Homo sapiens, Severe acute respiratory syndrome coronavirus 2
Sample: SARS-CoV-2 BA.1 S6P (HexaPro) + COV2-3835 Fab
Fitted models: 9nvg

Deposition Authors: Ramamohan AR , Johnson NV , McLellan JS
Epitope-focused discovery of SARS-CoV-2 antibodies that potently neutralize Omicron variants.
Zost SJ, Suryadevara N, Williamson LE, Scheaffer SM, Binshtein E, Buchman CD, Johnson NV , Catanzaro NJ, Ravera S, Chapman NS, Myers L, Ramamohan AR , Handal LS, Nguyen DC, Trivette A, Martinez JR, Villalobos E, Rutherford SA, Eun-Hyung Lee F, Schafer A, Baric RS, McLellan JS , Diamond MS, Carnahan RH, Crowe Jr JE
(2026) Nat Microbiol , 11 , 1113 - 1132
PUBMED: 41820555
DOI: doi:10.1038/s41564-026-02282-x
ISSN: 2058-5276
Grant Support: